Back
HUTCHMED (China) Vs. Pharmaron Beijing Industry Stock Comparison
Buy
72
HCM
HUTCHMED (China)
Last Price:
19.03
Seasonality Move:
2.07%
Sell
14
PHBBF
Pharmaron Beijing
Last Price:
2.25
Seasonality Move:
--
Buy
72
HUTCHMED (China) (HCM)
is a Buy
Is HUTCHMED (China) a Buy, Sell or Hold?
- The current HUTCHMED (China) [HCM] share price is $19.56. The Score for HCM is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- HCM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
Pharmaron Beijing (PHBBF)
is a Sell
Is Pharmaron Beijing a Buy, Sell or Hold?
- The current Pharmaron Beijing [PHBBF] share price is $2.25. The Score for PHBBF is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- PHBBF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HCM Stock Price Chart
What is HUTCHMED (China)'s stock price today?
-
The HUTCHMED (China) share price today is $19.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HCM is experiencing buying pressure, which is a positive indicator for future bullish movement.
PHBBF Stock Price Chart
What is Pharmaron Beijing's stock price today?
-
The Pharmaron Beijing share price today is $2.25
The current trend is relatively stagnant and PHBBF is experiencing slight buying pressure.
HCM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 64.89 | Buy |
| Chaikin Money Flow: | 111553 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.62 - 18.5) | Buy |
| Bollinger Bands (100): | (14.32 - 18.06) | Buy |
PHBBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 0 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.25 - 2.25) | Sell |
| Bollinger Bands (100): | (2.25 - 2.25) | Sell |
HCM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.69 | Buy |
| 20-day SMA: | 17.74 | Buy |
| 50-day SMA: | 16.81 | Buy |
| 200-day SMA: | 16.29 | Buy |
| 8-day EMA: | 18.59 | Buy |
| 20-day EMA: | 17.91 | Buy |
| 50-day EMA: | 17.05 | Buy |
| 200-day EMA: | 16.18 | Buy |
PHBBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.25 | Sell |
| 20-day SMA: | 2.25 | Sell |
| 50-day SMA: | 2.25 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 2.25 | Sell |
| 20-day EMA: | 2.25 | Sell |
| 50-day EMA: | 2.25 | Sell |
| 200-day EMA: | 0.52 | Buy |
HUTCHMED (China) Earnings Growth & HCM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.54 per share.
Pharmaron Beijing Earnings Growth & PHBBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
HUTCHMED (China) Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pharmaron Beijing Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||